CDA Issues Positive Reimbursement Recommendation for SKYCLARYS™ (omaveloxolone), the Only Health Canada-Approved Treatment for Managing Friedreich Ataxia Français
Regional differences in disease burden make focus on Quebec and Eastern Canada especially important
TORONTO, July 29, 2025 /CNW/ - Biogen Canada Inc. is pleased to announce a significant step forward for Canadians living with Friedreich ataxia (FA), with the positive reimbursement recommendation by Canada's Drug Agency (CDA) Canadian Drug Expert Committee (CDEC) for SKYCLARYS™ (omaveloxolone) as a treatment for patients 16 years of age and older who meet certain criteria. 1 This milestone brings Canadians outside Quebec affected by this rare neurodegenerative disease a step closer to accessing the only approved therapy for the condition.
The CDA recommendation is based on an assessment of clinical trial and economic evidence with input from physicians, patients and caregivers. The clinical evidence presented was from the Phase II MOXIe Part 2 trial, which showed that SKYCLARYS significantly slowed neurological decline compared to placebo as measured by the modified Friedreich Ataxia Rating Scale (mFARS), a tool used to assess neurological decline and disease progression. The individuals enrolled in the clinical trial were monitored over a 48-week period and showed reduced decline in their abilities when performing activities of daily living, which are essential for maintaining independence. 2
"For individuals affected by this progressive genetic disease, even a modest slowing in disease progression can have a profound impact on their lives," said Stacey Lintern, Chief Executive Officer, Muscular Dystrophy Canada. "Friedreich ataxia is a life-limiting condition that has been marked by a lack of treatment options and longstanding unmet needs in Canada. The CDA recommendation represents an important step toward changing that reality by making treatment more accessible and offering patients and families much-needed choice in managing their condition. Advancements like SKYCLARYS bring renewed hope to patients and their families."
A progressive and life-shortening genetic disease, FA has a devastating impact on those diagnosed, reducing quality of life and limiting life expectancy to an average of 37 years. 3,4,5 In Canada, it is estimated to affect 1 in 40,000 individuals. 6
"We are encouraged by the CDA's recognition of SKYCLARYS as vital therapy for the Friedreich ataxia community, representing critical progress for this life-altering disease in urgent need of treatment options. In regions like Quebec and Eastern Canada, where more people are affected by FA, the need for timely access to new treatment options is especially urgent," said François-Olivier Théberge, General Manager of Ataxia Canada. "FA takes a heavy toll—people and families living with the disease face significant and often overwhelming challenges. For over 53 years, Ataxia Canada has been driven by the vision of our founder, Claude St-Jean, who believed deeply in the power of science and community to bring hope to those affected by rare diseases. We remain committed to his mission to advocate for equitable access in all provinces, including Quebec, and look forward to helping ensure that all Canadians living with Friedreich ataxia have a fair chance to benefit from SKYCLARYS."
The CDA recommendation marks an important turning point in improving treatment options for individuals living with Friedreich ataxia.
"This milestone represents much needed progress in addressing a longstanding unmet need for Canadians living with Friedreich ataxia," said Eric Tse, General Manager, Biogen Canada Inc. "Biogen is proud to be at the forefront of innovation in rare and serious neurodegenerative diseases, and remains committed to working collaboratively with healthcare systems and decision makers across Canada to support timely and equitable access to a treatment that will set the new standard of care in the management of FA."
About Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment, to deliver long-term growth.
Biogen has been proudly serving Canadian patients for more than 25 years. For information about Biogen Canada, please visit www.biogen.ca.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
14 hours ago
- Winnipeg Free Press
Canadian aid agencies call for action saying starvation is rampant in Gaza
TORONTO – Canadian aid agencies say malnutrition and starvation is rampant among children in Gaza, as well as among the aid workers trying to help them. The Toronto-based president and CEO at Save the Children says its clinics are inundated by 200 to 300 people arriving each day. Danny Glenwright says there's been a tenfold increase in the number of children suffering acute malnutrition over the past two months, and that even clinic staff are bringing their children in for help. That's echoed by Canada's executive director of Doctors Without Borders, with Sana Beg adding that members of her organization have had to donate their own blood because supplies are so short. Beg says Doctors Without Borders welcomes Canada's recent denunciation of the Israeli government for failing to prevent the humanitarian crisis but called for concrete actions as well. Glenwright says average Canadians can help by urging their local MP to have Canada press for a definitive ceasefire and for all borders to open to aid trucks carrying desperately needed food and medical supplies. International experts have warned that a 'worst-case scenario of famine' is playing out in Gaza, where Israel's military offensive against Hamas has made it nearly impossible to safely deliver food to starving people. Glenwright said Friday that Canadians should be upset by the crisis, calling it 'a profound moral, political, and legal failure.' 'There's no food anywhere else in Gaza and the limited supplies we have are running out,' said Glenwright, whose agency has a clinics in Khan Younis and one in Deir al Balah. 'The trucks that are sitting on the border — thousands of them with these life-saving supplies — are not being allowed in at the scale that is required. And it's a calamity.' Several aid agencies detailed a near-total collapse of the humanitarian system in a press conference Tuesday in London that included members of Oxfam, War Child Alliance, Save the Children International in Gaza and the Palestinian Non-Governmental Organizations Network. Prime Minister Mark Carney on Thursday accused the Israeli government of violating international law by denying aid as it controls aid distribution, and called on all sides to negotiate an immediate ceasefire. Glenwright suggested Canada could do much more diplomatically and economically, noting how strongly the country mobilized to help Ukraine. 'Our government's inability to do more is shameful to all of us,' Glenwright said. 'Canadians can pressure their government – call your MP, say that you want candidates to do much more.' – With files from The Associated Press. This report by The Canadian Press was first published Aug. 1, 2025.
Cision Canada
17 hours ago
- Cision Canada
Government of Canada expanding health care to more Indigenous communities
SASKATOON, SK, Aug. 1, 2025 /CNW/ - The Government of Canada is committed to helping small and medium-sized businesses transform their innovative ideas into real-world solutions, ensuring that communities from coast to coast to coast benefit from their creativity and ingenuity. Today, the Honourable Buckley Belanger, Secretary of State (Rural Development), announced that the Virtual Health Hub (VHH) has joined the Coordinated Accessible National (CAN) Health Network. Having invested $42 million in the CAN Health Network since 2019, the Government of Canada is pleased to see this new partnership help improve access to health care in Saskatchewan's remote, rural and northern communities. Secretary of State Belanger also announced that two new projects are being launched through the CAN Health Network and VHH. Virtual reality technology from Saskatchewan's Luxsonic Technologies will support faster, more accurate diagnoses in remote areas. Digital technology from Nova Scotia–based Virtual Hallway will enable family physicians to consult with specialists more quickly, improving access to expert care across the network. In the nearly five years since the CAN Health Network was established, it has successfully connected 99 Canadian businesses working in health technology with different orders of government across the country. It is enabling entrepreneurs across Canada to grow, while strengthening our universal health care system by encouraging homegrown innovation. Quotes "The CAN Health Network is critical for helping Canadian innovations grow and succeed. By connecting organizations like the Virtual Health Hub with homegrown companies such as Luxonic and Virtual Hallway, the CAN Health Network is not only advancing cutting-edge technology but also supporting Canadian businesses, helping create jobs and driving economic growth across the country." – The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions "By investing in the CAN Health Network, we're doing two things at once: supporting Canadian businesses with smart new health care ideas, and helping patients get better care closer to home. The addition of the Virtual Health Hub will make it easier for rural, remote and Indigenous communities in Saskatchewan to access cutting-edge care. On behalf of the Government of Canada, I offer my congratulations to both teams on making it happen." – The Honourable Buckley Belanger, Secretary of State (Rural Development) "Universal, accessible and publicly funded health care is a point of pride for Canadians and underpins our economic strength. Health care innovation can not only improve patient outcomes and support health workers but also contribute to building a stronger Canada, where everyone, including people in Indigenous, remote and rural communities, has better access to care." – The Honourable Marjorie Michel, Minister of Health "This partnership with the Virtual Health Hub and the projects we're launching with Luxonic and Virtual Hallway show how Canadian-made innovation can drive economic growth and strengthen our communities. By bringing together organizations from across the country, we're building a stronger economy, creating jobs, supporting local industries and ensuring that technologies developed in Canada are helping Canadians, including those in rural and remote regions." – Dr. Dante Morra, Founder and Chair, CAN Health Network Quick facts The Government of Canada has invested $42 million since 2019 to support the growth and expansion of the Coordinated Accessible National (CAN) Health Network. Since its launch, the CAN Health Network has grown to include 50 Edges. Edges are health care operators, including health authorities and organizations. To date, the CAN Health Network has supported 99 innovative Canadian health care technology businesses. Under the initiative, 127 commercialization projects have been rolled out. As of April 25, 2025, 2,331 jobs have been created. The CAN Health Network has helped generate more than $698 million in revenue. Stay connected For easy access to government programs for businesses, download the Canada Business app.
Cision Canada
21 hours ago
- Cision Canada
CABHI launches AgeTech Insights to shape the future of aging Français
TORONTO, Aug. 1, 2025 /CNW/ - The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, launched AgeTech Insights at the Global Dementia Research + Innovation Showcase, its flagship event during the Alzheimer's Association International Conference (AAIC) 2025. The novel hub will help drive Canadian innovation by mobilizing knowledge and sharing market intelligence in the aging and brain health sector. "AgeTech Insights shares critical knowledge with entrepreneurs, investors, innovators, ecosystem builders, and policymakers to gain a deeper understanding of the current technology trends among older persons in Canada and around the world," said Dr. Allison Sekuler, President and Chief Scientist at CABHI and the Baycrest Academy for Research and Education. "These insights will ensure innovations are designed to meet the needs of older persons while advancing economic growth, in line with demographic trends as they shift in our country." As an innovation catalyst, CABHI supports innovators—scientists, researchers, clinicians, startup companies, and healthcare organizations—at all stages of their innovation journey. From helping early-career scientists and researchers join the innovation ecosystem through the CABHI Science Collaborative, to supporting innovators develop, test, and refine their solutions through the NextGen Support Package and Ignite, all the way to helping AgeTech companies with growth and scale through Fuel. AgeTech Insights will complement these efforts by identifying gaps, highlighting trends, and informing the development of age-inclusive solutions. Canada is facing a historic demographic shift with nearly one in five Canadians over the age of 65, and that number is set to rise dramatically. This change is reshaping the country's economy and health systems, creating an urgent demand for innovation in aging and brain health. CABHI's AgeTech Insights is designed to help meet this demand. The announcement took place during the Global Dementia Research + Innovation Showcase, attended by over 300 guests, including Michelle Cooper, Parliamentary Assistant to the Minister of Finance, Member of the Standing Committee on Public Accounts, and Member of Provincial Parliament for Eglinton—Lawrence, and Laura Smith, First Vice-Chair, Standing Committee on Procedure and House Affairs, Parliamentary Assistant to the Minister of Municipal Affairs and Housing (Housing), Member of the Standing Committee on Government, and Member of Provincial Parliament for Thornhill. AgeTech Insights will serve as a national and global knowledge hub to inform scientists, researchers, innovators, entrepreneurs, and policymakers on the needs of older persons while unlocking opportunities in the rapidly growing AgeTech market. "Ontario-made research is driving our economy and improving lives across the province," said Nolan Quinn, Minister of Colleges, Universities, Research and Excellence. "Our government is proud to support the Centre of Aging + Brain Health and commend their newest hub, AgeTech Insights, which will further advance discoveries at postsecondary and research institutions, leading to better, stronger brain health care for seniors in Ontario." AgeTech Insights launched with its first market intelligence report, offering insights into technology use in Canadians aged 50+, shedding light on barriers and enablers, and informing innovators how to apply this intelligence to their work. CABHI will share insights from Canadians aged 50+ through reports and knowledge products in collaboration with national and international ecosystem partners. By tracking, analyzing, and disseminating global trends, AgeTech Insights will influence innovation design, uptake, and policy in Canada, positioning the country as a global AgeTech leader. Learn more about the first AgeTech Insights Report and other knowledge products online on CABHI's website. About the Centre for Aging + Brain Health Innovation: The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, was established in 2015 to support researchers, clinicians, and innovators, as they develop and adopt transformative innovations that improve the lives of older persons, including those impacted by dementia. CABHI is a unique collaboration of healthcare, science, industry, not-for-profit, and government partners. Through its funding programs and tailored acceleration services, including access to diverse end-user groups, CABHI advances transformative aging and brain health innovations across Canada and the world. For more information, visit: About Baycrest: At Baycrest, our vision is a world where every older person lives with purpose, fulfilment and dignity. Baycrest is a global leader in aging and brain health innovation, with over 105 years of expertise in seniors' care and cutting-edge research. Baycrest has been Designated with Exemplary Status by Accreditation Canada, and drives industry-leading care and safety outcomes. As the home of the Centre for Aging + Brain Health Innovation (CABHI) powered by Baycrest, the Baycrest Academy for Research and Education (BARE) and the Canadian Consortium on Neurodegeneration in Aging, Baycrest is at the forefront of dementia research. Affiliated with the University of Toronto, Baycrest's training programs shape the future of care globally, while Baycrest Global Solutions extends its expertise to senior living and healthcare internationally. For more information, visit:
